Spyre Therapeutics, Inc. (SYRE)
41.04
-1.45
(-3.41%)
USD |
NASDAQ |
Mar 03, 14:08
Spyre Therapeutics Total Assets (Quarterly) : 777.78M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 301.85M |
| PTC Therapeutics, Inc. | 2.911B |
| Agios Pharmaceuticals, Inc. | 1.297B |
| Tandem Diabetes Care, Inc. | 881.11M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.54M |
| Shareholders Equity (Quarterly) | 715.24M |
| Current Ratio | 13.25 |